Infectious Diseases Catalyst Grants
Catalytic grants support innovative research on antimicrobial resistance or pandemic influenza with strong potential for direct human health impact.
Funder: Novo Nordisk Foundation
Due Dates (Anticipated): May 2026 | May 2027
Funding Amounts: Up to DKK 4 million (single PI, Nordic-based) or DKK 7 million (collaborative, Nordic + international co-applicant) per grant, up to 3 years; total call budget DKK 60 million.
Summary: Catalytic grants for innovative research on antimicrobial resistance or pandemic influenza with strong potential for direct global impact.
Key Information: Main applicant must be at least 75% employed at a Nordic non-profit research institution; only one application per person per cycle.
Description
The Infectious Diseases Catalyst Grants program supports exploratory, use-inspired, and innovative research projects aimed at addressing major global challenges in human infectious diseases. For the 2026 and 2027 cycles, projects must focus on one of two themes: (1) Novel antimicrobial resistance (AMR) tools—rational, innovative approaches to prevent, diagnose, or treat antimicrobial-resistant bacterial infections (priority to WHO Bacterial Priority Pathogen List pathogens); or (2) Pandemic Influenza—research targeting key gaps in understanding viral infectivity, transmission, and disease severity, and supporting the development of tools to prevent or combat pandemic influenza. Projects must enhance fundamental knowledge with a clear path toward application or translation for human health benefit.
